(MedPage Today) — The dual GIP/GLP-1 receptor agonist tirzepatide (Mounjaro, Zepbound) was just as cardioprotective as the GLP-1 drug dulaglutide (Trulicity) in patients with type 2 diabetes and atherosclerotic cardiovascular disease, a large…
Physicians want N.L. to hit pause on a mandatory, province-wide electronic health information system
Doctors in Newfoundland and Labrador says quick implementation of a province-wide electronic health information system threatens to harm patients and...






